病毒性肺炎是儿科常见病、多发病 ,近年有增多的趋势。由于临床治疗无特效药物 ,致使治疗困难 ;同时因伴有合并症 ,临床大量应用抗菌素 ,导致机体菌群紊乱 ,诱发耐药菌株或霉菌的生长。病毒唑、干扰素等抗病药物疗效常受感染时间及副作用的影响。为探索一种安全有效的治疗病毒 Viral pneumonia is a common pediatric disease, frequently-occurring disease, an increasing trend in recent years. Due to the clinical treatment of non-specific drugs, resulting in treatment difficulties; the same time due to complications, clinically large-scale use of antibiotics, leading to bacterial flora disorder, induced drug-resistant strains or mold growth. Ribavirin, interferon and other disease-resistant drugs often affected by the time of infection and side effects. To explore a safe and effective treatment of the virus